VIOLET
AI egg quality assessment
Company describes a personalized egg-quality report for egg-freezing patients, using machine learning trained on over 650,000 oocyte images to predict blastocyst development and live-birth likelihood.
Learn moreToronto company selling VIOLET, MAGENTA and ROSE, AI tools that assess egg quality for egg freezing, IVF and donor-egg programs at fertility clinics worldwide.

Canadian innovation builds a brighter tomorrow.
Toronto company selling VIOLET, MAGENTA and ROSE, AI tools that assess egg quality for egg freezing, IVF and donor-egg programs at fertility clinics worldwide.
Ontario Business Corp. FUTURE FERTILITY INC., status Active, registered office in Toronto, incorporated 2017-08-08. ised-isde.canada.ca
Raised a $7.6M CAD ($6M USD) Series A in January 2022 led by M Ventures (Merck KGaA's venture arm) with Whitecap Venture Partners participating. betakit.com
FedDev Ontario awarded $555,239 in May 2026 to commercialize a new AI-powered technology for assessing endometrial receptivity. canada.ca
VIOLET, MAGENTA and ROSE are deployed in over 300 fertility clinics across more than 35 countries. futurefertility.com
Products Future Fertility publishes on its own site. Each card links to the page it was taken from.
AI egg quality assessment
Company describes a personalized egg-quality report for egg-freezing patients, using machine learning trained on over 650,000 oocyte images to predict blastocyst development and live-birth likelihood.
Learn moreAI egg quality assessment
Company describes an AI-powered egg-quality report for IVF patients, trained on over 150,000 oocyte images, giving individual quality scores before egg collection.
Learn moreAI egg quality assessment
Company describes a purpose-built egg-quality assessment solution for donor egg programs and egg banks.
Learn moreAnnounced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
Jan 6, 2022
Investors: M Ventures, Whitecap Venture Partners
Government support actually received. Unpublished amounts are left out.
FedDev Ontario — commercialization of AI-powered endometrial receptivity assessment technology
Regional Artificial Intelligence Initiative (RAII), Federal Economic Development Agency for Southern Ontario
Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada
Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada
Industrial Research Assistance Program – AI Assist, National Research Council Canada
Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada
CanExport SME, National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
CanExport SME, National Research Council Canada
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution
FedDev Ontario announced $555,239 in funding for Future Fertility to commercialize a new AI-powered technology aimed at improving the current standard for assessing endometrial receptivity, as part of nearly $16.5 million awarded to 13 GTA companies.
Future Fertility closed a Series A led by M Ventures with Whitecap Venture Partners participating, reported at $7.6M CAD ($6M USD), to advance its Violet egg-quality assessment software.
Sourced from the company's own pages or announcements.
Dr. Dan Nayot
Co-Founder & Chief Medical Officer
Christy Prada
Chief Executive Officer
Terms the company uses about its own work.
Other companies in AI.
Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.